Antiviral therapy for recurrent hepatitis C after liver transplantation and its effect on liver fibrosis

Antiviral therapy for recurrent hepatitis C after liver transplantation and its effect on liver fibrosis

ObjectiveTo perform antiviral therapy in patients with recurrent hepatitis C after liver transplantation and to study the efficacy of antiviral therapy and its effect on the progression of liver fibrosis. MethodsTwenty-three patients with recurrent hepatitis C after liver transplantation who were ad...

Full description

Bibliographic Details
Main Author:	ZHOU Shuangnan
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2014-01-01
Series:	Linchuang Gandanbing Zazhi
Subjects:	liver transplantation; hepatitis C; antiviral agents; liver cirrhosis
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=5592&ClassID=1128144025

Similar Items

Features of HCV recurrence in patients with HCV-related cirrhosis after liver transplantation and its antiviral and immunomodulatory therapies
by: JIAO Jian
Published: (2014-01-01)

Efficiency of Antiviral Therapy for Recurrence of Chronic Hepatitis C in Patients Undergoing Liver Transplantation
by: A. A. Sukhoruk, et al.
Published: (2014-09-01)

Management of hepatitis c genotype 4 in the liver transplant setting
by: Waleed K Al-hamoudi
Published: (2016-01-01)

Antiviral therapy for hepatitis B/C virus-related cirrhosis
by: LI Yuyuan
Published: (2014-07-01)

Antiviral therapy of HCV in the cirrhotic and transplant candidate
Published: (2006-04-01)

POSSIBILITIES OF HEPATITIS C ANTIVIRAL TREATMENT IN LIVER TRANSPLANT RECIPIENTS
by: V. E. Syutkin, et al.
Published: (2011-06-01)

The epidemiological profile of chronic hepatitis C with advanced hepatic fibrosis regarding virus genotype in Taiwan: A nationwide study
by: Grace Hui-Min Wu, et al.
Published: (2021-07-01)

IL-2 Receptor Antagonist (Basiliximab) Is Associated with Rapid Fibrosis Progression in Patients with Recurrent Hepatitis C after Liver Transplantation
by: Ibrahim A. Hanouneh, et al.
Published: (2010-01-01)

EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS
by: M. V. Chistyakova, et al.
Published: (2017-01-01)

Antiviral therapy of hepatitis C with 1 genotype after liver transplantation
by: O. M. Tsiroulnikova, et al.
Published: (2018-09-01)

Research progress in antiviral therapy for decompensated hepatitis B cirrhosis
by: TU Yanyun
Published: (2015-03-01)

Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
by: Christian Mölleken, et al.
Published: (2019-03-01)

Liver fibrosis assessment by transient elastography in patients with liver cirrhosis after hepatitis C virus eradication
by: E. A. Nabatchikova, et al.
Published: (2020-03-01)

Outcome of early vs. deferred antiviral treatment for recurrent hepatitis C in liver transplant recipients
by: Isabel Campos-Varela, et al.
Published: (2014-03-01)

Recurrent hepatitis C treatment with direct acting antivirals – a real life study at a Brazilian liver transplant center
by: L.P. Zanaga, et al.

Influence of antiviral drugs combined with antioxidant therapy on liver injury and fibrosis process in patients with chronic hepatitis B cirrhosis
by: Guo-Yun Wan1, et al.
Published: (2017-05-01)

Clinico-laboratory and immunological characteristics of patients with compensated cirrhosis of the liver in the outcome of chronic hepatitis C on the background of treatment with a direct antiviral drug paritrapeprir/ritonavir/ombitasvir/ dasabuvir
by: L. L. Popova, et al.
Published: (2018-12-01)

Antiviral therapy of HCV-cirrhosis: case of sequential treatment and review of literature
by: Kakharman Yesmembetov, et al.
Published: (2018-03-01)

Role of liver transplantation in severe alcoholic hepatitis
by: Ravi Daswani, et al.
Published: (2018-03-01)

TREATMENT OF HEPATITIS C WITHOUT INTERFERON IN PATIENTS UNDERGOING LIVER TRANSPLANTATION
by: M. Sh. Khubutia, et al.
Published: (2015-10-01)

Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort
by: Bernuth S, et al.
Published: (2017-07-01)

Grading antiviral therapy in HCV-infected cirrhotic patients
by: ZHANG Ying
Published: (2013-02-01)

The impact of hepatitis E infection on hepatic fibrosis in liver transplanted patients for hepatitis C infection
by: Adriano Claudio Pereira de Moraes, et al.
Published: (2021-05-01)

Long-Term Follow-Up of Advanced Liver Disease after Sustained Virological Response to Treatment of Hepatitis C with Direct-Acting Antivirals: Outcomes from a Real-World Portuguese Cohort
by: Tiago Pereira Guedes, et al.
Published: (2019-10-01)

LIVER TRANSPLANTATION IN HEPATITIS DELTA: SOUTH AMERICA EXPERIENCE
by: Daniel Souza LIMA, et al.

Antiviral therapy in patients with HCV-cirrhosis
by: Josep Melero, et al.
Published: (2009-10-01)

ACUTE HEPATITIS С ON THE BACKGROUND OF LIVER Cirrhosis IN THE OUTCOME OF CHRONIC HEPATITIS C: CLINICAL CASE
by: V. G. Morozov, et al.
Published: (2018-01-01)

Treatment of hepatitis C in liver transplant recipients in the Moscow Center for Liver Transplantation within 10 years
by: M. Sh. Khubutia, et al.
Published: (2016-01-01)

Management of HCV Infection and Liver Transplantation
Published: (2006-04-01)

Therapeutic effect of antiviral therapy in chronic hepatitis B patients with nonalcoholic fatty liver disease
by: YING Ruosu
Published: (2013-08-01)

Outcomes of liver transplantation in the era of modern antiviral therapy for hepatitis C
by: K. Yu. Kokina, et al.
Published: (2021-04-01)

The evaluation of liver fibrosis regression in chronic hepatitis C patients after the treatment with direct-acting antiviral agents – A review of the literature
by: Olga H. Orasan, et al.
Published: (2019-10-01)

The long-term prospective study of patients with liver cirrhosis after elimination of the hepatitis C virus
by: E. A. Nabatchikova, et al.
Published: (2020-02-01)

The use of sofosbuvir for the treatment of recurrent hepatitis C after liver transplantation
by: M. Sh. Khubutiya, et al.
Published: (2017-03-01)

Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? – Treatment of Patients with Decompensated Cirrhosis
by: Geum-Youn Gwak
Published: (2016-03-01)

Cognitive impairment after liver transplantation: residual hepatic encephalopathy or posttransplant encephalopathy?
by: Kornerup LS, et al.
Published: (2019-03-01)

Outcomes in Hepatitis C Positive Liver Transplantation: Timing of Direct-Acting Antiviral Treatment and Impact on Graft Fibrosis
by: Jennifer Wellington, et al.
Published: (2021-09-01)

The use of telaprevir for the treatment of hepatitis C in patients undergoing liver transplantation (Literature review and clinical experience)
by: M. Sh. Khubutiya, et al.
Published: (2016-02-01)

The Patient Bomb: Sustained Viral Response after Hepatitis C in Cirrhosis
by: Rui António Rocha Tato Marinho
Published: (2020-02-01)

One-Year Outcomes after Ledipasvir/Sofosbuvir Treatment of Chronic Hepatitis C in Teenagers with and without Significant Liver Fibrosis—A Case Series Report
by: Maria Pokorska-Śpiewak, et al.
Published: (2021-07-01)